tradmap

SION Earnings Sionna Therapeutics, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$16 -$8 $0 2024 2025
EPS
Net income (annual)
-$75M -$38M $0 2024 2025
Net income
Return on equity (annual)
-25% 7% 38% 0% 2024 2025
ROE

Quarterly results

Diluted EPS (quarterly)
-$6540 -$3270 $0 Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26
EPS
Net income (quarterly)
-$30M -$15M $0 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26
Net income
Return on equity (quarterly)
-11% 3% 17% 0% Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26
ROE

Reported EPS history

1–10 of 10
Q2 20262026-06-30-1.252026-08-0610-Q
Q1 20262026-03-31-0.602026-05-1210-Q
FY 20252025-12-31-1.882026-03-0210-K
Q3 20252025-09-30-1.432025-11-0510-Q
Q2 20262025-06-30-0.982026-08-0610-Q
Q1 20262025-03-31-0.622026-05-1210-Q
FY 20252024-12-31-15.992026-03-0210-K
Q3 20252024-09-30-12.812025-11-0510-Q
Q2 20252024-06-30-6540.002025-08-1110-Q
Q1 20252024-03-31-3840.002025-05-1210-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.